21 CFR 820.184
Lack of or inadequate DHR procedures
- Inspections citing it: 1,888
- Of those classified, ended OAI: 20%
- Last cited: FY2026
Inspections Citing It by Fiscal Year
Sites in and outside the US, FY2017 to Oct 20, 2026.
Paragraphs Cited
As FDA posts them, all years.
- 820.184
- 1,751 · Lack of or inadequate DHR procedures
- 820.184(f)
- 51 · DHR - UDI not included
- 820.184(d)
- 47 · Acceptance records
- 820.184(e)
- 31 · ID label, labeling
- 820.184(b)
- 8 · Quantity manufactured
Regulation Text
eCFR did not answer; open it on eCFRRecently Cited Sites
Newest inspections citing this section; each opens the site- Marson Medical, Inc.United States · Jan 16, 2026
- Encore LaboratoryUnited States · Jan 9, 2026
- Peter Schiff EnterprisesUnited States · Dec 31, 2025
- Ashland Specialty Ingredients, G.P.United States · Dec 22, 2025
- Amphenol DC Electronics Inc.United States · Oct 23, 2025
- Sheffield Pharmaceuticals, LLCUnited States · Jun 18, 2025
- Bio-Med Devices, Inc.United States · Dec 20, 2024
- Glottal Enterprises Inc.United States · Oct 17, 2024
- NeuroMetrix, Inc.United States · May 7, 2015
- BL Healthcare, IncorporatedUnited States · Mar 30, 2015
- Noreaster Medical LLCUnited States · Dec 16, 2014
- Wassenburg Medical, Inc.United States · Nov 19, 2014
Counts are inspections with posted citations that cite any paragraph of the section, once per inspection, from FDA's Data Dashboard. OAI share is over inspections FDA finally classified. Text from eCFR, the official online CFR. FDA Data Dashboard and eCFR